126 related articles for article (PubMed ID: 37282796)
1. Transcriptomics, proteomics, metabolomics and network pharmacology reveal molecular mechanisms of multi-targets effects of Shenxianshengmai improving human iPSC-CMs beating.
Hu Y; Chen L; Zhao S; Feng R; Cao X; Chen G; Zhao T; Zhang C; Fang Z; Guo Z; Yu X; Zhang Z; Abdurahman M; Hong H; He Y; Li H
Clin Transl Med; 2023 Jun; 13(6):e1302. PubMed ID: 37282796
[No Abstract] [Full Text] [Related]
2. Integrated network pharmacology, transcriptomics, and metabolomics analysis to reveal the mechanism of salt Eucommiae cortex in the treatment of chronic kidney disease mineral bone disorders via the PPARG/AMPK signaling pathway.
Shen J; Liu Y; Wang Q; Chen H; Hu Y; Guo X; Liu X; Li Y
J Ethnopharmacol; 2023 Oct; 314():116590. PubMed ID: 37207881
[TBL] [Abstract][Full Text] [Related]
3. Proteomics in the World of Induced Pluripotent Stem Cells.
Lindoso RS; Kasai-Brunswick TH; Monnerat Cahli G; Collino F; Bastos Carvalho A; Campos de Carvalho AC; Vieyra A
Cells; 2019 Jul; 8(7):. PubMed ID: 31336746
[TBL] [Abstract][Full Text] [Related]
4. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus.
Tang L; Wang H; Dai B; Wang X; Zhou D; Shen J; Guo F; Wang J; Zhou J; Wang H; Wu Q; Yao H; Gong T; Su J; Meng ZX; Niu T; Zhang L; Liang P
J Mol Cell Cardiol; 2020 May; 142():53-64. PubMed ID: 32251671
[TBL] [Abstract][Full Text] [Related]
5. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.
Zhao P; Li J; Yang L; Li Y; Tian Y; Li S
Mol Med Rep; 2018 Apr; 17(4):5247-5257. PubMed ID: 29393428
[TBL] [Abstract][Full Text] [Related]
6. Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD.
Zhao P; Yang L; Li J; Li Y; Tian Y; Li S
Int J Chron Obstruct Pulmon Dis; 2016; 11():553-66. PubMed ID: 27042044
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Patel D; Stohlman J; Dang Q; Strauss DG; Blinova K
Toxicol Sci; 2019 Jul; 170(1):167-179. PubMed ID: 30912807
[TBL] [Abstract][Full Text] [Related]
8. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
[TBL] [Abstract][Full Text] [Related]
9. Integrated Ca
Malkovskiy AV; Ignatyeva N; Dai Y; Hasenfuss G; Rajadas J; Ebert A
Biol Chem; 2020 Nov; 402(1):113-121. PubMed ID: 33544492
[TBL] [Abstract][Full Text] [Related]
10. Integrating metabolomics and network pharmacology to reveal the mechanisms of Delphinium brunonianum extract against nonalcoholic steatohepatitis.
Zhang K; Yuan Y; Dawa Z; Liu F; Yao Y; Wang M; Zhu C; Lin C
J Ethnopharmacol; 2022 Jul; 293():115268. PubMed ID: 35398502
[TBL] [Abstract][Full Text] [Related]
11. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
[TBL] [Abstract][Full Text] [Related]
12. Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
Yuan Q; Deng D; Pan C; Ren J; Wei T; Wu Z; Zhang B; Li S; Yin P; Shang D
Front Immunol; 2022; 13():951137. PubMed ID: 35990657
[TBL] [Abstract][Full Text] [Related]
13. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
[TBL] [Abstract][Full Text] [Related]
14. A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation.
Shinozawa T; Furukawa H; Sato E; Takami K
J Biomol Screen; 2012 Jun; 17(5):683-91. PubMed ID: 22274911
[TBL] [Abstract][Full Text] [Related]
15. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
[TBL] [Abstract][Full Text] [Related]
16. Integration of transcriptomics, proteomics and metabolomics data to reveal the biological mechanisms of abrin injury in human lung epithelial cells.
Zhu W; Yu H; Wang Y; Chang Y; Wan J; Xu N; Wang J; Liu W
Toxicol Lett; 2019 Sep; 312():1-10. PubMed ID: 31054353
[TBL] [Abstract][Full Text] [Related]
17. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
[TBL] [Abstract][Full Text] [Related]
18. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
[TBL] [Abstract][Full Text] [Related]
19. Cell-Based Assays Using Differentiated Human Induced Pluripotent Cells.
Cader Z; Graf M; Burcin M; Mandenius CF; Ross JA
Methods Mol Biol; 2019; 1994():1-14. PubMed ID: 31124100
[TBL] [Abstract][Full Text] [Related]
20. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.
Cyganek L; Tiburcy M; Sekeres K; Gerstenberg K; Bohnenberger H; Lenz C; Henze S; Stauske M; Salinas G; Zimmermann WH; Hasenfuss G; Guan K
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]